| INSIGHT MOLECULAR DIAGNOSTICS |
| USA |
| Gesundheit |
| US68235C2061 / A3EQV9 |
| 7OC0 (Frankfurt) / IMDX (NASDAQ) |
| FRA:7OC0, ETR:7OC0, 7OC0:GR, NASDAQ:IMDX |
| - |
| https://imdxinc.com/ |
|
Insight Molecular Diagnostics Inc. is a precision diagnostics company specializing in the development and commercialization of advanced molecular diagnostic tests for both clinical and research applications. With a core focus on transplant medicine a..
>Volltext.. |
| 134.93 Mio. EUR |
| 112.56 Mio. EUR |
| 1.69 Mio. EUR |
| -28.25 Mio. EUR |
| -41.39 Mio. EUR |
| -1.28 EUR |
| 2.66 Mio. EUR |
| 25.03 Mio. EUR |
| -20.73 Mio. EUR |
| 2.41 |
| -49.28% |
| 17.81% |
| - |
| - |
| - |
| - |
| INSIGHT MOLECULAR |
| 11.08.26 |